A New CD10 Antibody Inhibits the Growth of Malignant Mesothelioma

Malignant mesotheliomas (MMs) are aggressive therapy-resistant tumors that generally have a poor prognosis. We previously reported the establishment of four new monoclonal antibodies (mAbs) for the diagnosis and treatment of MM. In this report, we characterized one of these antibodies, JMAM-1. The m...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizutani, Natsuko, Abe, Masaaki, Kajino, Kazunori, Matsuoka, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910416/
https://www.ncbi.nlm.nih.gov/pubmed/33625287
http://dx.doi.org/10.1089/mab.2020.0033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910416/
https://www.ncbi.nlm.nih.gov/pubmed/33625287
http://dx.doi.org/10.1089/mab.2020.0033

Ejemplares similares